Cargando…
Letter to the Editor in response to the article ‘Candidate drugs against SARS-CoV-2 and COVID-19’
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641521/ https://www.ncbi.nlm.nih.gov/pubmed/33160068 http://dx.doi.org/10.1016/j.phrs.2020.105285 |
| _version_ | 1783605932340543488 |
|---|---|
| author | Campesi, Ilaria Montella, Andrea Franconi, Flavia |
| author_facet | Campesi, Ilaria Montella, Andrea Franconi, Flavia |
| author_sort | Campesi, Ilaria |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7641521 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76415212020-11-05 Letter to the Editor in response to the article ‘Candidate drugs against SARS-CoV-2 and COVID-19’ Campesi, Ilaria Montella, Andrea Franconi, Flavia Pharmacol Res Article Elsevier Ltd. 2021-01 2020-11-04 /pmc/articles/PMC7641521/ /pubmed/33160068 http://dx.doi.org/10.1016/j.phrs.2020.105285 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Campesi, Ilaria Montella, Andrea Franconi, Flavia Letter to the Editor in response to the article ‘Candidate drugs against SARS-CoV-2 and COVID-19’ |
| title | Letter to the Editor in response to the article ‘Candidate drugs against SARS-CoV-2 and COVID-19’ |
| title_full | Letter to the Editor in response to the article ‘Candidate drugs against SARS-CoV-2 and COVID-19’ |
| title_fullStr | Letter to the Editor in response to the article ‘Candidate drugs against SARS-CoV-2 and COVID-19’ |
| title_full_unstemmed | Letter to the Editor in response to the article ‘Candidate drugs against SARS-CoV-2 and COVID-19’ |
| title_short | Letter to the Editor in response to the article ‘Candidate drugs against SARS-CoV-2 and COVID-19’ |
| title_sort | letter to the editor in response to the article ‘candidate drugs against sars-cov-2 and covid-19’ |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641521/ https://www.ncbi.nlm.nih.gov/pubmed/33160068 http://dx.doi.org/10.1016/j.phrs.2020.105285 |
| work_keys_str_mv | AT campesiilaria lettertotheeditorinresponsetothearticlecandidatedrugsagainstsarscov2andcovid19 AT montellaandrea lettertotheeditorinresponsetothearticlecandidatedrugsagainstsarscov2andcovid19 AT franconiflavia lettertotheeditorinresponsetothearticlecandidatedrugsagainstsarscov2andcovid19 |